Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 8-K Event Executive or director change
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 8-K Event Executive or director change · Shareholder vote results
  14. 8-K Event Other events
  15. 4 Planned sale Chief Legal Officer sold 2,615 shares at $22.15 ($57,916)
  16. 144 Insider Sale of Securities
  17. SC 13G Stake Amended Statement of Ownership
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. ARS Other Annual Report to Security Holders

Page 11 of 41 · 809 filings